| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Secretome Therapeutics Revolutionizing cell therapy for inflammatory diseases via neonatal cardiac progenitor cells and their secretomes Revolutionizing cell therapy to address inflammatory diseases driven via neonatal cardiac progenitor cells and their secretomes. 260 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 13 |
 | Chromodynamics Taking the guesswork out of drug development At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis 250 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 7 |
 |  Cradle Design better proteins. We believe Cells can theoretically produce almost anything, from fabrics to food, fuel and medicines. Designing cell-factories is hard, but our tools and machine-learning models can make it easier. Our mission is to ultimately help replace traditional farms and factories for a more sustainable world. Jobs: https://jobs.cradle.bio protein design, machine learning, protein activity, protein stability, protein secretability, protein , protein structure, metabolic engineering, protein engineering, and protein solubility 79 similar entities Type: Startup Activities: biotech Technologies: Synthetic Biology | 4 | 75 |
 | Ferment We incubate, fund, and launch new companies that use programmed biology to shape the human future. Ferment is a venture studio building new companies that rapidly translate biology into products that solve targeted problems across industrial and consumer markets including food & nutrition, industrials & waste, materials, consumer health and more. synbio, synthetic biology, biotech, programmed biology, venture studio, company creation studio, incubator, venture capital, biotechnology, industrial biotechnology, and consumer biotechnology 122 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 8 |
 |  Atoxigen ATOXIGEN is your partner in early R&D. We offer a variety of standardized or customized assays based on the latest innovations in the fields of cellular biology, molecular biology and genomics. Innovative predictive efficacy assays on reconstructed epidermis or primary cell lines from human explants (proteasome, autophagy, detoxification, anti-ageing...); in vitro genotoxicity testing (micronucleus and chromosome aberration tests); endocrine disruptor screening; customized services. Biotechnologies, Testing & Research, Evaluation toxicologique, and Assurance qualité 88 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 3 |
 |  INOVACTIS Versatile immunotherapy for personalized cancer medicine Inovactis develops an innovative treatment against cancer at the border between several ongoing revolutions: individualized medicine, immunotherapy and synthetic biology. personalized immunotherapy and medicine 101 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 |
 | Scienta Lab AI-powered Precision Immunology Scienta Lab is a deeptech company developing a unique and proprietary artificial intelligence technology to transform the drug discovery and development process in immunology and inflammation. Artificial Intelligence, Clinical Trials, and Immunology 120 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. | 20 | 17 |
 | Meccellis Biotech French manufacturer of biologic implants Meccellis Biotech is a company expert in Tissue and Cell Engineering with a diversified offer for multiple surgical specialties. After 7 years of marketing, Meccellis Biotech is now present in 25 countries. The passion and professionalism of its teams have made of Meccellis Biotech, a reference company for the manufacturing of biomaterials. For any further information you may need regarding our range of biologic implants, please feel free to contact us: contact@meccellis.com - Phone number: +33 (0) 5 17 81 07 63 - THE MECCELLIS BIOTECH TEAM Breast reconstruction: CELLIS Breast, General surgery: CELLIS, and … 20 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 12 | 11 |
 | StarkAge Therapeutics Immunotherapy against senescence StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs. 69 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 11 |
 | AGV Discovery AGV Discovery offers services in chemistry, cell biology, in vitro screening, rational drug design, outsourcing and consultancy. AGV Discovery is a pharmaceutics that specializes in rational design and early development of drug candidates. 61 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 0 | 7 |
 | NUMAFERM Biomade Peptides We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production. 66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 18 |
 | Archon Biosciences Pioneering next-generation antibody therapies with AI and computational protein design Archon is a biotechnology company developing computationally designed proteins to unlock powerful therapeutic targets that lie beyond the reach of existing modalities and to better treat disease. We directly apply generative protein design to create a new biologic class, Antibody Cages (AbCs), that integrates the industry-proven affinity and specificity of antibodies into self-assembling nanostructures. Precise control over AbC structure provides the ability to tune both how they distribute in the body and engage their cellular targets with high specificity and potency to establish a new gold-standard for biologic medicines. Archon … 61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 23 |
 | Avenue Biosciences Transforming protein biologics with groundbreaking high-throughput protein engineering. Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, … 142 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 11 |
 | VerImmune Redirecting Immune Memory from Pathogens or Childhood Vaccines to Target Cancer VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer 188 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 13 |
 | CytoTronics Visualize live-cell function at scale. CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique insights to drug discovery. A revolutionary approach to studying cell biology, powered by microchips. Electrophysiology, CMOS, Phenotypic Screening, Electrochemistry, Cell measurement, and Cell manipulation 87 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 31 |
 | Aplantex Innovation: the core of our DNA Aplantex has been created by a team of entrepreneurs and scientific specialists after a careful validation of the technical concept first formulated in 2019. With the support of our academic and industrial partners, we are now aiming at producing a large catalog of high value plant-based active ingredients to be used within the pharmaceutical, cosmetics and agri-food markets. Our proprietary technology builds on the latest scientific developments in the "omics" field, with a practical, low cost and easily scalable industrial approach. By mastering, redirecting and optimizing the metabolism of our photosynthetic phytoreplicators, we are … 31 similar entities Type: Startup Activities: deeptech biotech | 0 | 13 |
 | Kano Therapeutics Complete genes for complete cures Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them. Biotechnology, DNA therapeutics, Gene therapy, CRISPR, and Biological engineering 113 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 16 |
 | Cell BioEngines, Inc ‘Off-the-Shelf’ Curative Cell Therapies About Us: Cell BioEngines, Inc., founded in Dec 2022, is a clinical-stage biotech company focused on developing allogeneic 'off-the-shelf' stem cell and its derived therapies as ‘drugs’ for human disease treatment. The company utilizes a ‘plug-and-play’ proprietary platform technology that transforms universal ‘non-gene-modified’ donor blood stem cells from umbilical cord, to produce high-quality, pure and potent, multiple clinical grade cells at scale. This innovative method aims to make stem cells and its derived therapies more accessible and efficient. Its lead product is currently in Phase 1 trials for the treatment of hematopoetiic neoplasms not curable with … 75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 |
 | Sarcura Powering New Possibles in Cell Therapy Manufacturing Cell therapy has transformed cancer treatment, yet the hurdles of manufacturing patient-derived cell therapies remain a formidable challenge for the industry. Quality and scalability problems lead to high therapeutic costs and limit access to those life-saving treatments. By harnessing the power of cutting-edge semiconductor technologies, including silicon photonics seamlessly integrated into microfluidic cartridges, Sarcura is orchestrating a transformative shift. Central to Sarcura's mission is the creation of fully automated manufacturing systems endowed with real-time process and product control. This pioneering platform promises to usher in a new era of cost-effective and secure cell … 20 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 28 |
 | Immunic Therapeutics Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/ 66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 84 |
 | Belyntic GmbH The Precision Vaccines Company Belyntic creates novel vaccines for viral diseases with unmet medical need. We have developed and validated a new platform technology, that generates self-adjuvant synthetic long peptides for a safe and durable induction of cellular immunity. Drug development, Cellular immunity, and Platform technology 165 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 2 |
 | OXGENE A WuXi Advanced Therapies company, based in Oxford, UK. OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENETM is headquartered in Oxford, UK. For additional information, please visit our website. PRODUCTS: Largest collection of standardised plasmids on the market and SERVICES: DNA Services, Protein Production Services, Virus Services, Cell Line Development Services. 52 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 5 | 26 |
 | a:head bio AG we aim to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids a:head’s drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini brains from human stem cells in vitro. They capture the essential aspects of human embryonic brain development including brain patterning, formation of brain ventricles, differentiation into the various neuronal and supportive cell types and their correct three-dimensional arrangement. The technology has been pioneered by the company’s co-founders Madeline Lancaster and Juergen Knoblich and is exclusively licensed to a:head by the Institute of … 21 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 18 |
 | Hervolution Therapeutics Therapeutics for the Disease of Aging Immune therapy platform targeting Dark Genome antigens that contribute to aging, cancer, diabetes, and neurodegenerative diseases Oncology, Aging, Dark Genome, ALS, Diabetes, and Longevity 198 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 23 |
 | Alternative Plants Cellular farmers using biotechnology to unlock the full potential of botanical resources. A biotech company dedicated to production of cosmetic ingredients from plant stem cells. We focus on cell cultures of endangered Nordic plants thus using plant biotechnology to make inaccessible treasures accessible. The value we provide is not only a new ingredient - our routine is scrupulous chemical characterisation and efficacy testing to deliver excellent ingredients along with a set of ready-to-use efficacy claims. Cosmetic ingredients, Plant derived active ingredients, In vitro efficacy testing, Anti-ageing ingredients, Skin whitening ingredients, Antioxidants, Plant cell culture, Organic ingredients, and Efficacy claiming Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 9 |
 | LinKinVax LinKinVax aims at creating a universal, safe, enduring, vaccines platform against multiple pathogens. We are a clinical stage Biotech Spin-off of the Vaccine Research Institute in France with a unique "DC targeting" platform covering infectious desaeses and oncology. 161 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 2 |
 | AdipoPharma SAS French biotech company targeting the Adipocyte to treat insulin resistance, type 2 diabetes and associated comorbidities AdipoPharma SAS is a French biotech company with a US subsidiary committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis. Our first-in-class candidate - PATAS - is set to enter clinical trials later this year. 75 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 23 | 74 |
 | kyron.bio Next generation bioproduction platform Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical … 69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 7 |
 | CLEAN BIOLOGICS Making it possible CLEAN BIOLOGICS is a CDMO for Viral vectors, Viral vaccines and oncolytic viruses and Biosafety testing for biological products. As well as a CMO for MCB & WCB production. GMP compliance 63 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 14 | 11 |
 | LabSkin Creations Your Skin Designer LabSkin Creations is a biotechnology company specializing in advanced 3D skin and adipose tissue engineering. By combining innovative cell culture techniques as well as proprietary technologies based on scaffolding biomaterials and 3D bioprinting approaches, LabSkin designs and creates unique and versatile 3D reconstructed models for the performance evaluation of skin and personal care products and their ingredients. tests d'activité et d'efficacité, analyse d'image, Histologie, Immunohistochimie, Biologie cutanée, 3D, Reconstructed skin, and Adipose Tissue 63 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology | 6 | 11 |
 | NETRI INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology 62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 52 | 38 |
 | Kolibri Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech 137 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 14 | 13 |
 | Vivet Therapeutics Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression. Gene Therapy 91 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 20 |
 | Cherry Biotech Alternative to Animal Testing for Drug Development Cherry Biotech is a biomedical technology (Organ on Chip) company that develops instruments for drug discovery and personalised medicine. Its mission is to replace animal testing by reconstructing human tissue (Organoids) in vitro for drug testing. Cherry Biotech's CUBIX platform enables pharmaceutical, biotech companies and healthcare providers to recreate immunocompetent human vascularized organ models and tumor microenvironments for better evaluation of their drug candidates. By enabling the reconstruction of human 3D models that mimic human physiology and pathophysiology over several weeks, Cherry Biotech's proprietary CUBIX technology is the only solution that can convert … 56 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 24 |
 | Bioxis Pharmaceuticals #BeyondInnovation #DermalFiller #CYTOSIAL #AestheticMedicine New ideas, new innovations, new ways of thinking for the medical device industry. We are a pharmaceutical company specialized in the discovery, clinical development, production and commercialization of innovative products in the field of regenerative medicine. At Bioxis Pharmaceuticals, we contribute to transform science into groundbreaking medical device that meet doctors need to improve the health and well-being of their patients in the field of dermatology and aesthetic medicine. Medical Device, Dermatology, Aesthetic, Cosmetic surgery, Regenerative medicine, Ultra-pure chitosan, and Hyaluronic Acid 301 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology | 5 | 28 |
 | Logos Biosystems See beyond your cells. Advanced imaging solutions for research excellence. Logos Biosystems is the life science solutions of Aligned Genetics, Inc., dedicated to the development and commercialization of innovative technologies to support the life science research community. Since its founding in 2008, Logos Biosystems has been developing a series of automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis. 20 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 23 |
 | TENSIVE SRL Advanced Biomaterials for Regenerative Medicine Tensive is a biomedical company developing advanced biomaterials for regenerative medicine applications, with a current focus on reconstructive surgery after breast cancer. 122 similar entities Type: Startup Activities: deeptech healthtech Technologies: New Materials Synthetic Biology | 0 | 30 |
 | Neo-Bionica We turn medical devices into clinical reality Neo-Bionica bridges the gap between research and the clinic, providing world-class engineering expertise and links to leading clinicians to create life changing medical device solutions. Offering end-to-end medical device prototype development, from initial concept and rapid prototyping, to pre-clinical testing and first-in-human prototypes for clinical trials 120 similar entities Type: Startup Activities: deeptech healthtech biotech manufacturing Technologies: Synthetic Biology | 0 | 16 |
 | CELLforCURE by Seqens Trustworthy development and commercial manufacturing of CELL&GENE therapies On december 1st 2023, Seqens completed the acquisition of CELLforCURE. Originally a versatile CELL&GENE CDMO, CELLforCURE gained thorough experience in commercial CAR-T cells manufacturing. With 2 200m2 GMP production areas, 6 equipped production suites and 180 seasoned highly skilled experts, CELLforCURE offers versatile and flexible capacities. Located in France, 20km away from the Paris Orly Airport, CELLforCURE is an EMA approved production site and is compliant with FDA standards. The site brings analytical, development and regulatory services to serve client needs across the overall product life cycle. CELLforCURE teams aim at partnering … 21 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology | 7 | 100 |
 | ExAdEx-Innov Shaping the future of in vitro preclinical research Unique R&D platform of donor-derived real human adipose tissue ex vivo for pharmaceutical drug development (obesity, chronic metabolic diseases), dermo-cosmetic, nutraceutical, aesthetic and reconstructive surgery research. ExAdEx-Innov owns exclusive worldwide rights to ExAdEx patented breakthrough technology from French academic laboratories of excellence (Côte d’Azur University, Institut de Biologie Valrose, CNRS, INSERM, University Hospital of Nice) and is supported by SATT Sud-Est, IdEX Université Côte d'Azur, CNRS Innovation, Provence Côte d'Azur Business Incubator, Métropôle Nice Côte d’Azur and Eurobiomed Healthtech Accelerator. adipose tissue, cosmetic testing, research platform, in vitro, ex vivo, models, obesity, … 100 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 22 | 6 |
 | Advesya Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune 398 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 11 | 14 |
 | LYMPHOBANK Ready -to -use cell bank, for research, for patients Lymphobank - Bank of ready -to -use cells, for research, for patients. Lymphobank is a biotech specializing in the supply of adult and placental -use -for -use blood cells, the characteristics of which will be available online (www.lymphobank.fr), allowing the cellular product to be chosen according to an interest donor. Our services are focused on the development of cellular immunotherapy products. In addition, Lymphobank develops an innovative approach to allogenic adoptive immunotherapy of hepatocellular carcinoma (the most frequent liver cancers and second cause of cancer death in the world, with nearly … 62 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 2 |
 | Priothera SAS Adding Quality Years of Life We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) 207 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 14 | 20 |
 | Neocor Therapeutics Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology 118 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 4 |
 | SMARTOX Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library 336 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 8 |
 | DeepLife AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, … 91 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning SaaS | 22 | 29 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … 83 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 18 | 133 |
 | Phenocell Phenocell is a research-based biotechnology company specialized in the creation, production, and commercialization of cellular models & bioassays for research and drug discovery. We are your designated partner for open innovation projects, let's reach out! Using the Nobel-prize winning technology of cellular reprogramming, we create foot-print free, feeder-free, hiPSC that are further differentiated into somatic cells and amenable to 3D projects. Large batches of qualified cells can be produced and used in unique phenotypic assays to repurpose existing drugs or discover new compounds. Phenocell has specific expertise in the production of: -human skin cells: sebocytes, melanocytes and keratinocytes -human retinal … 67 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 10 |
 | Machine Bio Machine Bio is a biotech company offering unique protein synthesis and purification solutions. Machine Bio is an early stage biotechnology company developing a novel, proprietary protein synthesis platform that can produce pure protein from a DNA template in a easy-to-use, single-step, 4 hour process. Proteins are broadly used in many industries and Machine Bio’s platform has a range of possible applications across drug discovery and development, synthetic biology research, industrial enzyme optimization, and commercial therapeutic manufacturing. Protein Synthesis, Protein Purification, Contract Protein Expression, R&D, Startup, Cell-Free Systems, and Supported Lipid Bilayer 71 similar entities Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 1 | 5 |
 | Biomecanica Orthopedic implants and prosthesis industry with over 36 years of history, trust and transparency. Founded in 1988, Biomecanica is based in Jaú, interior of São Paulo, with one of the most advanced industrial parks in Latin America, Biomechananica has 120 employees, 1,000 products in line, 5,000 sub-items in manufacturing, not to mention the Stars line products. Biomecanica invests in state -of -the -art machining equipment, as well as having a laboratory in its infrastructure, with ISO 7 and ISO 5 certifications (aseptic mode) provided by Anvisa itself for biomaterial production. With the partnership of the most qualified distributors, we reached … 38 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 190 |
 | Greiner Bio-One International making a difference Greiner Bio-One: Innovative solutions for your hospitals, laboratories and research facilities We specialize in the development, production and distribution of high-quality plastic products for laboratories worldwide. As a reliable technology partner, we support hospitals, research institutions, laboratories as well as the diagnostic, pharmaceutical and biotechnology industries with customized solutions. Our focus: ☑ Preanalytics: We are setting new standards in safety and efficiency with innovative collection systems for blood, urine and saliva sampling. Our customized digital solutions (Greiner eHealth Technologies) optimize processes and increase patient safety in laboratories and medical practices. ☑ BioScience: We offer highly specialized products … 52 similar entities Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 2 | 609 |
 | HemostOD Inspired by platelet biology to save lives. We engineer and manufacture platelets. platelets, biotechnology, bioengineering, stem cells, on demand, biodrug, in vitro manufacturing, Bioprocess, blood platelets, alloimmunization, thrombocytopenia, blood cancer, leukemia, transfusion, HSCT, Stem cell, Hematology, biologics, drug, biopharma, drug development, healthcare, allogenic therapy, drug delivery, miRNA, siRNA, targeted delivery, and targeted drug delivery 62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 10 |
 | Integra Therapeutics Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases At Integra Therapeutics we have combined the precision of CRISPR systems with the gene transfer efficiency of viral integrases and transposases. Harnessing what nature has evolved to introduce large pieces of DNA into the genome, together with the precision of sequence specific DNA binding proteins, has allowed for unprecedented efficiency in programmable gene delivery. 112 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 22 |
 | Inscripta, Inc. The Digital Genome Engineering Company Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California. To learn more, visit Inscripta.com and follow @InscriptaInc. Digital Genome Engineering, Gene Editing, Synthetic Biology, Genome Editing, CRISPR, … 29 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 4 | 42 |
 | Turbine We are building the world’s leading predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s first open simulation platform of patient biology. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals 180 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology | 8 | 103 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinson's Disease. In 2022, the company opened a … 52 similar entities Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 51 | 179 |
 | Abtech Therapeutics Expertise in protein engineering | in silico & in vitro antibody discovery platform We work in partnership with technology platforms, pharmaceutical companies, and academic research groups to create next generation cell and molecular therapies. We integrate novel technologies into a synthetic antibody platform to provide the most advanced discovery engine possible. 259 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 |
 | Ingenza Ltd ADVANCED BY NATURE. Ingenza Ltd. is a boutique, employee-owned CRDMO that develops smarter bioprocesses across life sciences and industrial biotech. With over two decades of experience, Ingenza combines molecular biology, biocatalysis, and computational design into a platform-based approach that enables predictable, scalable, and efficient biomanufacturing. At the heart of our offering are proprietary inGenius platform that drive decision-making and accelerate development: codABLETM – our machine learning-driven gene optimization tool for intelligent codon selection and expression tuning Rapid Strain and Cell Line Development – modular workflows for host selection, expression screening, and stability assessment Integrated Process Development – upstream and downstream … 125 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 51 |
 | Immunocore Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI 264 similar entities Type: Startup Activities: deeptech hrtech biotech Technologies: Synthetic Biology | 10 | 574 |
 | Tiss'You Tiss’You – Regenerative Company – researches and develops medical devices to upgrade your body’s natural healing ability Tiss'You - Regenerative Company - researches and develops medical devices for regenerative medicine to help doctors and patients with innovative therapeutical solutions. Tiss'You is also a production facility of 850 sqm of which 240 sqm are clean rooms. We have next-generation equipments for R&D, production and quality control; 2 patents, 4 tissue substitutes and 2 point-of-care cell therapy devices. medicina rigenerativa, ricerca e sviluppo, clinica privata, prevenzione, innovazione, ortopedia, chirurgia vascolare, wound healing, lipocell, monocytes, integratori alimentari, regenerative medicine, food supplements, biomaterials, medical … 92 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 10 |
 | CytoSeek A cell-therapy technology company developing artificial membrane-binding proteins for oncology and regenerative medicine CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies. Our novel cell membrane augmentation technology enables us to add new functionalities to various therapeutic cells. CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health. Biochemistry, Immunology, Oncology, Regenerative Medicine, Cell therapies, and Proteins 81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 5 |
 | EOVE Inovative company specialized in the development and manufacture of medical devices EOVE develops and manufactures innovatives products to improve care and quality life with greater freedom for Adult ans Pediatric Patients who suffer from breathing disorders and chronic respiratory diseases. 219 similar entities Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology | 3 | 33 |
 | Contraline Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception. medical device, biotechnology, urology, contraception, womenshealth, reproductivehealth, and menshealth 136 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 2 | 23 |
 | Akron Bio Powering the future of medicine Since 2006, Akron’s mission is to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies. Akron’s newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards. Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to … Type: SMB Activities: deeptech manufacturing biotech Technologies: Synthetic Biology | 1 | 110 |
 | Jellagen A Revolutionary Platform for Regenerative Medicine Our jellyfish collagen-based innovation addresses complex regenerative medical needs, shaping next generation treatments and supporting current and future scientific research. At the heart of our products is marine-sourced Collagen Type 0, an evolutionary ancient stem collagen that is foundational, allowing greater applications across multiple indications. Medical Grade Collagen, Native Collagen, Cell Culture Reagents, Wound Healing, Hydrogels, Non Mammalian Collagen, Collagen, Reagents, Marine Biotechnology, regenerative medicine, 3dscaffolds, collagencoatedplates, and 3dsponges 37 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 13 |
 | NVH Medicinal The synthetic collagen revolution NVH Medicinal Global Expert in Synthetic Collagen NVH Medicinal is a Dijon -based biotechnology company, created at the end of 2008 whose mission is based on the treatment of pathologies linked to a collagen deficit. It develops products derived from collagen, the most abundant protein in the body and whose dysfunctions cause many diseases (aging, cardiovascular, inflammatory, neurological, fibrosis, cancer and rare diseases). NVH's ambition is to be recognized as an innovative player in the treatment of collagen -related diseases by becoming one of the global leaders in the development, production and marketing of a new … 60 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 0 | 3 |
 | PannTheraPi Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech 65 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 11 |
 | InVenis Biotherapies Platelet-derived Regenerative Therapy for CNS Disorders InVenis Biotherapies is a biotech compagny, spin-off from academic laboratory U1172 and Taipei Medical University, developping innovative regenerative therapies based on blood platelet. Thanks to the high therapeutic potential of our product, we target the most severe diseases involving cell death, as the amyotrophic lateral sclerosis. 217 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 2 |
 | e-Zyvec e-Zyvec services by Polyplus provide tailor-made plasmids that really fit your needs! e-Zyvec is a French Biotech Start-up founded in 2016 as a spin-off of the University of Lille 1. We are providing unique solutions in molecular biology to academical or industrial scientists working on research project with genetic engineering applications. Using our proprietary DNA assembly technology and our in-house developped web application, we can design and produce fully customized gene expression vectors, fitting exactly the requirements of your project. Getting vectors with e-zyvec is fast, accurate and unrestrictive. Molecular Biology and Genetic Enginnering 8 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology | 1 | 4 |
 | Mablink Bioscience Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D 70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 15 | 35 |
 | Cellforcure a NOVARTIS company CELLforCURE gathers all cell and gene therapies activities of the LFB group. With an annual production capability of several thousands of therapeutics batches, the Les Ulis CELLforCURE facility is the first modular entity in Europe to enable large scale industrial production for ATMPs. This platform operates on a mixed model of a CDMO (Contract Development and Manufacturing Organisation) providing large scale GMP and cGMP production services, for both clinical and commercial needs, and of a pharmaceutical company leading the development of cell and gene therapies medicinal products up to their launch on the market. CELLforCURE is an … 87 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology | 2 | 104 |
 | MEDSENIC New therapeutic targets based on arsenic trioxide (As2O3) Founded in 2010, MEDSENIC is a biopharmaceutical start-up that aims to exploit the new possibilities offered by the therapeutic use of arsenic trioxide (As2O3) and thereby provide a treatment for patients with autoimmune diseases. santé, biotechnologies, bioparma, biopharmaceutical, biotech, health, biotechnology, autoimmune diseases, and maladies auto-immunes 346 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 4 |
 | Ksilink Patient-based drug discovery We design and apply unique patient-based cellular assays for large-scale phenotypic screening, leaning on the power of AI-driven image analysis. Integrated from bed to bench and back to bed, we aim to generate most efficient first-in-class therapeutic molecules for next generation medicine. AI image and data analysis, biology, high content screening, high throughput screening, deep learning, assay development, patient stratification, pyschiatric disorders, and cardiac muscle 235 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology | 4 | 22 |
 | Kuur Therapeutics Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors. Immunotherapy, Cancer, Oncology, T cells, TCR, CAR, CAR-NKT, clinical trial, NKT Cells, celltherapy, and lifesciences 76 similar entities Type: SMB Activities: biotech deeptech transporttech Technologies: Synthetic Biology | 2 | 85 |
 | Cellvax Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera Cellvax, founded in 2001, is a preclinical CRO which provides innovating drug validation studies both in vitro and in vivo allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer and Osteoarthritis (OA) fields. Cellvax is a fast-growing technology-driven preclinical service company. Today, Cellvax directly employs and through R&D collaborations motivated and differently skilled scientists and engineers, working in interdisciplinary teams on several innovative products. Preclinical studies CRO, Animal models, Cancer, Osteoarthritis, Bio-markers, … 64 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 7 |
 | GENEPEP - PEPTIDE Peptide Chemistry company for design, synthesis, stability studies and chemical optimisation (SAR studies)- CIR agrement PEPTIDES, PEPTIDE LIBRARIES AND PROTEINS Innovative chemistry for therapeutic, diagnostic and cosmetic applications GENEPEP is a CRO company (with CIR agreement) focused on peptide synthesis & services : - Tools for nanoparticles & surface functionalization - Custom synthesis of peptides, proteins & peptide libraries - Catalog of toxins, peptides & pseudopeptides - Design & synthesis for SAR studies (optimisation of solubility, stability, efficacy,...) - Stability & solubility tests - Partner of European programs, ANR, FUI etc... 375 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 14 |
 | RD-BIOTECH Biomanufacturing, development & analytical services: Plasmids, Antibodies, Recombinant proteins, Cells - FastELISA kits French CRO Biotechnology 🔎 BIOMANUFACTURING: Plasmids (R&D and High Quality grades, And Now a pDNA GMP unit), Monoclonal antibodies, Recombinant antibodies (scFV, Fab, bispecific...), recombinant proteins (E.Coli, Cell free system, Yeast and mammalian cells), cells. 💡 Antibody engineering & molecular biology platforms: Antibody sequencing, vector design & cloning, Recombinant antibody production, Chimerization and Humanization, cell line development... ✍ Analytical services: immunoassays development, antibody characterisation, quality controls (R&D and high quality grades) FastELISA kits: Immunoglobulin quantification (human, mouse, rat, bovine), Mouse Immunoglobulin isotyping, Contaminant detection (Protein A), other … 80 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 16 | 59 |
 | Molecular Assemblies, Inc. DNA Synthesis Uncompromised Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company’s patented Fully Enzymatic Synthesis (or FESTM), based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. FES technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of nanomachines and bio-based electronics. Molecular Assemblies is headquartered in San Diego. *Fully Enzymatic Synthesis and FES are the trademarks of … 66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 10 |
 | Synthace Helping scientists solve the world's most pressing problems with faster, more powerful experiments. Synthace is a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. It allows biologists to design, plan, and automate experiments in a single place, then automatically gather structured experiment data and metadata in a unified no-code environment. Biotech, Life Sciences, Software, Lab Automation, Bioprocessing, Engineering Biology, and Programming 52 similar entities Type: Startup Activities: biotech deeptech Technologies: SaaS | 19 | 42 |
 | Bioptimus We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models 58 similar entities Type: Startup Activities: biotech it services Technologies: Generative A.I. A.I. | 15 | 28 |
 | Healshape A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products 61 similar entities Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology | 23 | 21 |
 | Corlieve Therapeutics At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders. Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders. 60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 |
 | Deeptope Advanced Antibody Expertise Deeptope's expertise lies in antibody charaterisation (epitope/paratope mapping) and optimisation using high throughput methods. antibody, paratope mapping, epitope mapping, and antibody optimisation 77 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 2 | 7 |
 | Sirius NeoSight New view for cancer Therapeutic Sirius Neosight is an innovative technological breakdown company which aims to become a key player in the detection of subclashed neo-cancers, relapses and therapeutic monitoring of patients thus offering a new look to doctors on the therapeutic efficiency implemented. Sirius Neosight operates a patented from a patented rupture technology from a consortium of academic laboratory experts in the field. 59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 19 | 7 |
 | Stent Up Stent'Up vise à sécuriser le traitement préventif des anévrismes cérébraux par la création d'un implant révolutionnaire. Stent Up, designs, manufactures, and markets medical devices dedicated to the treatment of strokes. 48 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology | 9 | 2 |
 | Cell&Soft Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish 35 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 6 |
 | Biossan your partner for preclinical research Biossan : A French CRO dedicated to biomedical research Biossan helps its academic and industrial partners develop their innovations by performing preclinical trials under controlled conditions. Biossan specializes in evaluating medical devices, new techniques, and pharmaceutical products in healthy and pathological models. Conduite et accompagnement de projet de recherche, Organisation de formation, and Bien-être et expérimentation animale 89 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 1 |
 | Naobios Biomanufacturing services Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches. 159 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology | 8 | 39 |
 | Coave Therapeutics Coave therapeutics Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet need and where success … 86 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 10 | 41 |
 | Medical Device Engineering MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices. We created MEDICAL DEVICE ENGINEERING S.A.S to bring innovators the missing link in the development of their medical devices and disposables. The concept of your therapy, or surgery has been proven from the medical point of view (PoC) and you need a device? Or you may simply have an idea and do not know where to start to make it concrete? Our Philosophy: A team composed of both Scientists & Engineers (plastics processing) to better understand each other, and to make … 64 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 8 |
 | CliniSciences Group Reagents and instruments for immunology, cell biology and molecular biology. CliniSciences commercialises reagents (antibodies, recombinants, ELISA kits, RNAi, cDNA clones, probes, PCR/qPCR reagents...) to diagnostic and research labs. As very dynamic company, we do our best to be close to our customers' needs in terms of high quality reagents that we propose and in terms of service that we provide (search for a particular antibody, technical support, delivery time, etc.) Our principal assets for better serving you : adaptability, flexibility, reactivity and naturally the competence of the technical specialists at your service. 76 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 70 |
 | Cell-Easy Your Cell-Therapy Specialized CDMO Cell-Easy is a CDMO specialized in Cell Therapy. We support biotech, pharma, and public institutions with GMP development and manufacturing. Our mission: accelerate your Cell Therapy’s path to market, with patient access as our priority. ATMPs are not conventional biologics — they are living drugs. Our team brings hands-on expertise in cell culture across all cell types, engineered or not, addressing challenges in development, GMP manufacturing, and QC. Beyond core CDMO services — process diagnostics, development, GMP production, cell banking, cryostorage, and delivery — we also support sourcing of human biological materials and clinical trial setup, … 80 similar entities Type: Startup Activities: biotech healthtech manufacturing Technologies: Synthetic Biology | 1 | 36 |
 | CEMENTIC Nano Life Sciences Cementic, founded in 2016, is a pioneering biotech startup with bases in Paris, France, and Palo Alto, USA. Specializing in cutting-edge nano-biotechnology solutions, our focus is on revolutionizing healthcare through innovative applications in dental care, orthopedics, and stem cell research. We leverage new paradigms to address complex health challenges, advancing global health from our dual locations. Medtech, Biotech, Dental, Orthopedics, Nanotechnolgies, Stem cells , and Liposomes 71 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 1 | 3 |
 | Okomera Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity 333 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 38 | 30 |
 | Minos Biosciences What You See Is What You Seq - Revolutionary cell analysis solution for fundamental, translational & pharma/biotech R&D Minos Biosciences is on the path to bridge molecular and cell biology in a manner never achieved before that will, in turn, allow scientists to uncover the full picture of cell diversity and dynamics. By combining multi-omics analysis with phenotypic analysis at cell resolution and at high throughput, Minos’ solution provides a new paradigm in cell analysis that will open up new frontiers in life science research, precision medicine and diagnostics. 66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 15 |
 | DiscoveryOrtho Partners A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation 520 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 2 |
 | Maxion Therapeutics Ion channel and GPCR drug discovery using innovative KnotBody technology Maxion uses its innovative KnotBody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and GPCR proteins. 186 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 35 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology 67 similar entities Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 45 | 159 |
 | AAVantgarde Bio Delivering the next generation gene therapies AAVantgarde is a clinical-stage, international biotechnology company (headquartered in Italy) that has developed two proprietary adeno-associated viral (AAV) vector platforms to address the DNA cargo capacity limitations of AAV vectors Gene Therapy, Ophthalmology, and Rare diseases 338 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 1 | 51 |
 | Bio-Works Technologies Next generation chromatography resins Bio-Works was founded in 2006 and is involved in R&D, manufacturing and supply of innovative, leading edge products used to separate proteins and other biomolecules. Our staff is rich in experience within the Swedish Life science industry and are specialized in resins for separation and purification. Bio-Works' research, development and production facilities are located in Uppsala, Sweden. We are actively working with sustainable development and our Quality Management System is based on ISO 9001:2015 standards. Bio-Works produces agarose based products with exceptional performance. These are used in academic research laboratories, biopharmaceutical companies, and many more areas. … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 48 |